En


EFMC Sponsored Event

January 19-23, 2020
St. Anton, Austria

The “Alpine Winter Conference on Medicinal and Synthetic Chemistry” exposes attending scientists to cutting edge synthetic and medicinal chemistry as well as latest developments in technologies that foster innovation in drug discovery. The main target audience for this highly interdisciplinary meeting will include medicinal and synthetic chemists, as well as related drug discovery disciplines from both industry and academia as well as graduate/undergraduate students and postdocs.

In the spirit of Keystone and Gordon conferences as well as the MBCF (Medicinal and Bioorganic Chemistry Foundation) conference in Steamboat Springs, the format of this meeting provides ample opportunity for attendees to informally interact. The aim is to strengthen existing networks and create new contacts.

The Conference topics will include:

  • Accelerating Drug Discovery by Intelligence Augmentation
  • Drug Discovery Tales
  • Frontiers of Synthetic Chemistry
  • Innovation and Inspiration from Natural Products
  • Predictive ADME Sciences: Striking a Balance Between in Silico and Experimental Work?
  • Protein Degradation: New Rules for Drug Discovery
  • Structure and Biophysics - Companions for Medicinal Chemistry
  • Targeted Delivery - Strategies to Help your Drug Substances get to the Right Place

Deadline for abstract submission and early bird fee is October 16, 2019!

For more information please contact: secretariat@ldorganisation.com


EFMC Sponsored Event

January 22-24, 2020
Geneva, Switzerland

The NCCR Chemical Biology is organising the 2020 International Symposium on Chemical Biology to be held from January 22 to 24, 2020 at Campus Biotech in Geneva. This international meeting of high scientific calibre will bring together leading scientists to feature the latest advances within the broad field of Chemical Biology and foster an open and dynamic dialogue!

New international collaborations and increased international visibility will hopefully be the outcome of this unique learning experience that comprises extensive poster sessions, ample time for discussion after each talk and opportunities for targeted networking.

Three hundred participants from Swiss universities, various research institutes in Switzerland and neighbouring countries are expected to attend.

Registration will close on December 16, 2019.

The number of participants is limited to 300.

For more information contact nccr-chembio@unige.ch

Jannuary 29-31, 2020
Caen, France
Organised by:
  • Société de Chimie Thérapeutique (France)


EFMC Sponsored Event

February 4, 2020
Basel, Switzerland

This one-day symposium co-organised by the Swiss Chemical Society, Division Medicinal Chemistry and Chemical Biology, and the Biological & Medicinal Chemistry Sector of the Royal Society of Chemistry, is dedicated to “Using Chemical Biology to identify new targets for Medicinal Chemistry”.

The topic of this second Anglo-Swiss symposium has been selected by our members among several proposals aiming at reinforcing the links between chemical biology, medicinal and agro chemistry, while being of importance in drug discovery and optimization programs.

Illustrating the role of chemical biology in the identification and validation of novel targets for medicinal chemistry will be of high interest to students in chemistry, pharmacy, biology, and to the medicinal chemistry and chemical biology community at large. The target audience is therefore composed of scientists from pharmaceutical and biotech industries, as well as colleagues from academia.

Confirmed Speakers:

  • Prof. Yimon Aye (EPFL Lausanne, Switzerland)
  • Dr. Mark Frigerio (Abzena, United kingdom)
  • Dr. Dominic Hoepfner (Novartis, Switzerland)
  • Prof. Maja Köhn (University of Freiburg, Germany)
  • Prof. Daniel Romo (Baylor University, United States)
  • Dr. Filip Roudnicky (F. Hoffmann-La Roche, Switzerland)
  • Prof. Stephan Sieber (TU Munich, Germany)
  • Prof. Kristian Strømgaard (University of Copenhagen, Denmark)

The deadline for poster submission is January 13, 2020

For more information please contact: 

Organised by:
  • Division for Medicinal Chemistry & Chemical Biology (DMCCB) (Switzerland)
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)


EFMC Sponsored Event

February 18-19, 2020
Cambridge, United Kingdom

The last decade has seen the rapid development of Late-stage functionalisation as a powerful method for enabling rapid SAR generation from a lead structure and allowing access to complex structures, biological probes and new chemical space where de-novo synthesis is not trivial. Both the inorganic catalyst and biocatalysis fields have seen new advancements over the last few years with the search for more efficient, selective, functional group tolerant, predictable methodology and new late stage transformations still a key focus. Not only are LSF methods of use in rapid SAR generation but are also finding great utility throughout the pharmaceutical industry, from metabolic identification to scale-up processes. The purpose of this meeting is to highlight some of the hot and emerging developments in the inorganic catalysis and biocatalysis arenas and both the academic and application of Late-stage functionalisation methodologies.

Early bird fees until December 13, 2019.

For more information contact: 

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)


EFMC Sponsored Event

Febraury 24-25, 2020
Cambridge, United Kingdom

Ion channels are important targets for therapeutic intervention due to their extensive roles in human physiology and the pathophysiology of disease. Many successful drugs targeting this gene family have been discovered for diseases such as hypertension, epilepsy and neuropathic pain. 

This symposium, the 6th in an ongoing series, will showcase the most recent advances to aid the design of new ion channel therapeutics and promote interaction between scientists with a shared interest in the field of ion channel drug discovery.

Deadline for abstract submission is November 15, 2019.

Early bird registration deadline is November 29, 2019.

Bursary application deadline is December 31, 2019.

Standard registration deadline is January 22, 2020.

For more information please contact: 

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)

March 22-25, 2020
Freiburg, Germany

The international symposium will focus on current developments, novel approaches and cutting-edge technologies in the field of medicinal chemistry and drug research with sessions on Chemical Proteomics – Activity based Protein Profiling, Macrocyclic and Covalent Inhibitors, Young Investigators, Novel Computational Methods, Epigenetics, and Highlights in Medicinal Chemistry and Case Studies. The scientific program will include lectures, and poster presentations. It is the goal of the organizers to make this meeting an event of scientific excellence, attractive to both industrial and academic scientists in Medicinal Chemistry, Chemical Biology, and related fields of research.

Deadline submission of oral presentations and poster is December 5, 2019

For more information contact: barabara.rees@pharmazie.uni-freiburg.de

 

Organised by:
  • Division of Medicinal Chemistry of the German Chemical Society (GDCh) (Germany)
  • German Pharmaceutical Society, Section of Pharmaceutical/Medicinal Chemistry (Germany)

March 22-26, 2020
Philadelphia, Pennsylvania

ACS organizes two national meetings & expositions each year, and each one attracts an estimated 11,000 to 13,000 chemists, chemical engineers, academicians, graduate and undergraduate students, and other related professionals. During the meeting, scientists present new multidisciplinary research, hear the latest information in their areas of professional interest, and network with colleagues. Programming is planned by our 33 technical divisions that cover all scientific fields, secretariats that focus on multidisciplinary programming, and ACS committees. Each meeting will feature more than 7,000 presentations organized into technical symposia that highlight important research advances with over 250 exhibitors showcasing new technological developments.

Contact person: Vanessa L. Johnson-Evans
Email:


EFMC Sponsored Event

March 23-24, 2020
Eindhoven, The Netherlands

The Conference topics will include:

  • G-protein coupled receptors
  • Protein-protein interactions
  • Activity-based protein profiling
  • Carbohydrates/glycans
  • Cellular chemistry
  • Bioorthogonal and bioconjugation chemistry
  • Fragment-based drug design
  • Photopharmacology
Organised by:
  • Division Medicinal Chemistry & Chemical Biology, Royal Netherlands Chemical Society (KNCV-MCCB) (The Netherlands)


EFMC Sponsored Event

March 27, 2020
Windlesham, United Kingdom

Synthesis is at the heart of drug discovery and development. The industry has increasingly demanded higher quality clinical candidates and has sought to exploit less druggable biological targets. Densely functionalised small molecules with a high degree of synthetic complexity are often the result of these demands. Successful programmes therefore require the application of innovative synthesis in all stages of discovery and development. The medicinal chemist’s toolbox is also enhanced by the introduction of novel biosostrere, often made available only through the application of new synthetic methods. This symposium aims to celebrate the crucial role of synthesis in the success of drug discovery and development.

The three main themes of the symposium will be:

• Innovative synthesis facilitating candidate discovery
• Novel bioisosteres and methodology applicable to drug discovery
• Overcoming challenges of scale-up and process scale chemistry

Abstract submission deadline is January 30, 2020.

Bursary application deadline is February 6, 2020.

For more information please contact: 

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)


EFMC Sponsored Event

April 14-15, 2020
San Francisco, United States

The identification of potential new therapeutic agents is met with significant challenges in preclinical discovery and development.  Both efficacy and safety endpoints must be adequately assessed prior to testing a new investigational agent in humans.  Perhaps the most challenging part of drug discovery is the mitigation of safety risks that arise during most drug discovery optimization efforts.  In order to design and make safer drug candidates, medicinal chemists work with cross-functional drug discovery partners to understand, assess and mitigate safety risks associated with potential new drug candidates.  Successful drug discovery teams will properly design and execute experiments that can best assess and discharge risks prior to first human dose (FHD).  This must be accomplished in the context of anticipated human drug exposures and patient risk-benefit analysis.  Through the lens of modern medicinal chemistry, this course explores the current best practices and methods used to identify, understand and mitigate common preclinical safety risks from both a strategic and tactical perspective.  Importantly, the course also describes proactive approaches that can help medicinal chemists avoid many safety issues and deliver safer small molecule drug candidates.  A key objective of the course is to improve medicinal chemist’s preparedness for participation and leadership on cross-functional drug discovery teams.

Course Outline:

  • Principles of toxicology and safety assessment.
  • The Investigational New Drug (IND) application.
  • Target assessment, predictive toxicology and in silico methods.
  • Preferred drug properties to minimize toxicological risks.
  • Common off-target safety concerns and mitigation.
  • Managing on-target safety concerns.
  • Pharmacokinetics in preclinical safety assessment.
  • Drug metabolism and bioactivation.
  • Toxicophores and Structure Alerts.
  • Mechanisms and mitigation strategies for Drug-Induced Liver Injury (DILI).
  • Preclinical safety biomarkers and translation to the clinic.
  • Clinical candidate selection and FHD enablement.

For more information contact: 

April 16-19, 2020
İstanbul, Turkey

For more information please contact : oyaunsal@hacettepe.edu.tr

Organised by:
  • Turkish Association of Medicinal and Pharmaceutical Chemistry (Turkey)


EFMC Sponsored Event

April 21, 2020
London, United Kingdom

Nucleosides are key structures for current drug development and have established roles as antivirals and anticancer agents. Their (poly)phosphorylated nucleotide counterparts are critical tools for chemical biology and sequencing technologies. In recent years, nucleotides have also become fundamental building blocks for the preparation of altered genes and coding systems for synthetic biology. This meeting seeks to explore and celebrate the chemistry that drives the development of modern nucleoside and nucleotide chemistry. It will bring together scientists who work at the interfaces of synthetic and biological chemistry to deliver new tools and insights for biology, and new leads for drug development.

Features of the Meeting
• Synthetic methodologies for the preparation of nucleosides, nucleotides and related molecules
• Applications for nucleosides and nucleotides as medicines
• Applications of nucleosides and nucleotides as tools for chemical biology and synthetic biology
• Plenary speakers, poster session and trade exhibition

Deadline for abstract submission for oral communication is January 6, 2020.

Early bird registartion deadline is January 22, 2020.

Bursary application deadline is March 9, 2020.

Deadline for abstract submission for poster presentation is March 11, 2020.

Standard registration deadline is March 19, 2020.

For more information please contact: 

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)


EFMC Sponsored Event

April 21-22, 2020
London, United Kingdom

Cell surface transporters play a key role in human health and disease, both through their impact on drug disposition and as therapeutic targets in their own right. This third meeting in the series will feature talks on transporter structural biology, the impact of transporters on ADME and biodistribution, transporters as therapeutic targets and other aspects of transporters relevant to drug discovery and development. 

For more information please contact: 

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)

April 27-29, 2020
Montpellier, France

The registration is now open for the conference “Cell-penetrating peptides: Next generation delivery systems” which is co-organized with the French Peptides and Proteins Group (GFPP).

This meeting will be held in Montpellier (France), from Monday 27th to Wednesday 29th of April 2020 in the Aimé Schoenig lecture hall of the Montpellier University.

This 3-days international symposium will focus on:

• Design and synthesis of CPPs, peptide-based nanoparticles, and other peptide-based delivery systems
• Biophysical, biochemical and/or cell biology approaches to study their interaction with model and/or biological membranes
• In vivo studies and therapeutic/clinical applications of peptide-based delivery systems

This scientific meeting is the continuation of conferences that have lasted for almost ten years, such as the meetings held in Tallinn (May 2011), Paris (July 2015) and Tartu (August 2018).

Deadline for oral communication submission: February 29th, 2020

Deadline for poster submission and registration: March 31th, 2020

April 29-30, 2020
Brunnen, Switzerland

The ‘SCS Conference on Stereochemistry’, better known as ‘Bürgenstock Conference’, is an outstanding international chemistry meeting of high scientific quality, with an optimal setting for intense inter-disciplinary discussion.

Stereochemistry is the principle underlying our understanding of the processes of life and the properties of matter at the molecular level. It is a key element not only in all chemical disciplines, but also in modern molecular biology, molecular medicine, biophysics, and material design. Accordingly, the ‘Bürgenstock Conference’ has grown over the years into a multi-disciplinary conference where frontier science is being discussed. Lectures cover many areas of chemistry and relevant highlights from neighboring disciplines.

For more information please contact: info@scg.ch

Organised by:
  • Division for Medicinal Chemistry & Chemical Biology (DMCCB) (Switzerland)


EFMC Sponsored Event

April 30, 2020
Hatfield, United Kingdom

The Symposium on Medicinal Chemistry in Eastern England, known colloquially as the "Hatfield MedChem" meeting, is a highly successful, long-standing, one-day meeting which runs annually. The scientific program will comprise presentations showcasing medicinal chemistry case studies from tools to candidates, across a range of modalities, therapeutic areas and target classes, as well as covering more general topics from the forefront of drug discovery of relevance to medicinal chemists. The meeting aims to be informal and interactive and the event will offer excellent scientific and networking opportunities for all those working in medicinal chemistry and drug discovery. 

Deadline for abstract submission is December 20, 2019.

For more information please contact: 

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)

May 2020
Szeged, Hungary
Organised by:
  • Organic and Medicinal Chemistry Division (OMCD) of the Hungarian Chemical Society (HCS) (Hungary)


EFMC Sponsored Event

May 5-6, 2020
Liverpool, United Kingdom

Members from across the DMPK research community are encouraged to join colleagues from across academic, industrial, and third-sector institutions and contribute to the ongoing discussion, evolution and application of DMPK in various scenarios.

The event programme will incorporate sessions themed around the following key topics:
- DMPK and Drug Discovery
- DMPK and Drug Safety
- Analytical and Computational Advances in DMPK

In addition, the programme also includes a keynote talk, ‘flash’ presentations from early career researchers, and opportunities for open debate and discussion.

Deadline for abstract submission is December 20, 2019.

For more information please contact: 

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)

May 7-9, 2020
Athens, Greece
Organised by:
  • Hellenic Society of Medicinal Chemistry (Greece)


EFMC Short Course

May 17-20, 2020
Oegstgeest (near Leiden), The Netherlands

This intensive course is intended for scientists working in the field, and the presentations will be given by senior scientists from industry and academia. The number of participants is limited to 35, to allow in depth discussion. Should the number of applications exceed the maximum, preference will be given to applicants from EFMC adhering countries and employees of EFMC corporate members. Upon special request to the organisers, only based on financial conditions and supported by an argued recommendation of the head of the department of the applicant, up to 3 applicants from academia may be admitted at a reduced fee.

Course Outline

G-protein coupled receptors represent the largest class of drug targets. Although they serve as targets for about 30% of the known drugs, many of them is still orphan. In the last 15 years, however, we witnessed dramatic developments in the structural biology and pharmacology of GPCRs. High resolution X-ray and cryo-EM structures made the design of the GPCR ligands more rational. The widening knowledge on their signalling resulted in new concepts such as allosteric modulation, GPCR residence time and biased signalling currently tested in clinical trials. This course will provide an introduction for medicinal chemists to this important target class including concepts and methods applied in the structural biology, modelling, systems biology, pharmacology and medicinal chemistry of GPCRs.  The course will finish with a series of medicinal chemistry case studies, including the discovery of molecular probes, tool compounds, clinical candidates and marketed drugs.

Course Organisers

György Miklós KESERÜ (Research Centre for Natural Sciences, Hungarian Academy of Sciences, Hungary)
Rob LEURS (VU University Amsterdam, The Netherlands)

Local Organisers
Henk TIMMERMAN (VU University Amsterdam, The Netherlands)
Laura HEITMAN (University of Leiden, The Netherlands)

June 2020
Serbia

For more information please contact: office@shd.org.rs

Organised by:
  • Serbian Chemical Society, Division of Medicinal Chemistry (Serbia)


EFMC Sponsored Event

June 1-2, 2020
London, United Kingdom

With more than 49 FDA-approved small molecules, the field of kinase inhibition continues to attract significant investment from the drug discovery and development community. The 9th RSC/SCI symposium on kinases will encompass plenary lectures on emergent topics and case studies of ongoing programmes as well as successful past programmes. A range of topics including new screening approaches, brain penetrant kinase inhibitors, induced protein degradation, allosteric inhibitors and kinase inhibition for immuno-oncology will be covered, along with views and perspectives on the future of kinase inhibitor research.

Deadline for abstract submission for oral communication is December 18, 2019.

Deadline for abstract submission for poster presentation is April 17, 2020.

For more information please contact: 

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)

June 3-5, 2020
Kuopio, Finland

The Chemical Sciences in Biological Challenges combines life and health sciences with bio- and natural sciences. In the conference chemical sciences meet the challenges of biological environments from the perspective of drug development, environmental sciences as well as circular economy. The Key note lecturers are the top scientists on the fields of various disciplines, e.g. NMR spectroscopy, pharmacology, medicinal chemistry, organic synthesis, peptide research etc.

For more information please contact: 

Organised by:
  • Finnish Pharmaceutical Society (Finland)


EFMC Sponsored Event

June 12, 2020
Newcastle, United Kingdom

Mastering Medicinal Chemistry VI is the latest in an ongoing series of conferences intended to provide expert advice and guidance to new practitioners in the field of drug discovery. It has been said that "there are two types of drug discovery programmes: those that hit serious problems and those that are going to hit serious problems". 

Anticipating and preparing for such problems thus accelerates the delivery of new medicines: this event will feature presentations from experienced 'drug-hunters' in both industry and academia, who will talk about the challenges faced in modern drug discovery, and will share best practice common to all successful medicinal chemists.

Deadline for bursary application is April 28, 2020.

Deadline for abstract submission for poster presentation is May 20, 2020.

For more information please contact: 

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)

June 16-18, 2020
Barcelona, Spain

The Seventh SEQT Summer School is organized by the Spanish Society of Medicinal Chemistry (SEQT) and Esteve Pharmaceuticals with the aim of approaching the pharma industry to young researchers, both graduate students and post-doctoral associates working in chemistry and health sciences related fields. The School will be held at Esteve R&D facilities in Barcelona. During three days, the participants will have the opportunity to learn about the latest research trends in pharmaceutical drug discovery and development.

For more inforation contact: 

Organised by:
  • Sociedad Española de Química Terapéutica (Spain)

June 18, 2020
Tel-Aviv, Israel
Organised by:
  • The Medicinal Chemistry Section of the Israel Chemical Society (Israel)

June 19, 2020
Barcelona, Spain

The Spanish Society of Medicinal Chemistry (SEQT) has the pleasure to invite you to join the 7th Symposium of Medicinal Chemistry Young Researchers. The meeting will be held in Barcelona Science Park on June19th, 2020. At this event, young scientists (Post-doc, Pre-doc, Master’s degree, and Bachelor’s degree students) will have the opportunity to present their work in the form of oral, flash and poster presentations. Besides, registration is also open to both junior and senior researchers. As in former editions, attendees will have the opportunity to show and discuss their results in Medicinal Chemistry, and related areas, such as pharmacology, organic synthesis, molecular biology, computational chemistry, chemical biology, natural products, biotechnology, biochemistry and crystallography.

For more inforation contact: 

Organised by:
  • Sociedad Española de Química Terapéutica (Spain)


EFMC Sponsored Event

June 24-26, 2020
Madrid, Spain

Tuberculosis, malaria and diseases caused by a diverse range of pathogens, including flaviviruses (eg dengue, West Nile), kinetoplastids (causative agents of Chagas disease, leishmaniasis, etc) and gut pathogens (worms, bacteria, parasites), remain a cause of high mortality across the globe. Fortunately, an ever-improving understanding of the complex life-cycles of these disease-causing pathogens is presenting increasing opportunities for those seeking to tackle these global health problems.

This meeting will focus on medicinal chemistry approaches to developing new medicines for diseases affecting global health. Keynote talks from international experts from industry and academia, alongside perspectives detailing case histories in drug discovery, will highlight the latest developments in the field whilst also showcasing the opportunity for creativity and innovation. 

Deadline for abstract submission is April 24, 2020.

For more information please contact: 


Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)
  • Sociedad Española de Química Terapéutica (Spain)

June 28-July 1, 2020
New York City, United States

The American Chemical Society, Division of Medicinal Chemistry, is glad to invite you to New York City from Sunday, June 28 to Wednesday, July 1, 2020, for the 37th edition of the National Medicinal Chemistry Symposium.

As per its tradition, this dynamic four day symposium aims to bring together medicinal chemists from across the country working in the pharmaceutical industry, academia, government and private research institutions.

Attendees will be updated on the emerging techniques and applications within the field, and are encouraged to submit abstracts to share their ideas and results. Several poster prizes will be awarded during the meeting.

The Program of the 37th NMCS will include the following Sessions:

  • Integrating Novel Chemical Modalities in Hit-to-lead: a New Paradigm for Early Drug Discovery
    Chair: Maria-Jesus Blanco (SAGE Therapeutics)

  • New Directions in Targeting DNA Damage Repair (DDR)
    Chairs: Erin DiMauro (Merck & Co. Inc.) and Srinivasa Karra (Alkermes, Inc.)

  • Hot Targets from NYC Academic and Biotech Scene
    Chairs: Robert DeVita (Icahn School of Medicine at Mt Sinai) and Amjad Ali (Merck & Co. Inc.)

  • Targeting Autophagy for Cancer, Neurodegeneration, or Autoimmune Disease
    Chairs: Erin DiMauro (Merck & Co. Inc.) and Hongjun Zhang (Merck & Co. Inc.)

  • “If At First You Don’t Succeed, Try, Try, Try Again”: How Clinical Failures Propelled Next Generation Candidates
    Chair: Matthew Volgraf (Genentech Inc.)

  • Lessons from Drug Hunters across Academia, NPOs and the Pharmaceutical Industry
    Chair: Phil Kym (AbbVie)

In addition, the Program will also feature an Award Session.

Online registration and accommodation booking will be available as of January 15, 2020. Only 150 early-bird tickets available!

Abstracts for poster presentations can be submitted until March 15, 2020.

For more information please contact:


EFMC Sponsored Event

July 1-3, 2020
Bordeaux, France

The French Medicinal Chemistry Society (Société de Chimie Thérapeutique - SCT) is pleased to invite you to Bordeaux, France on July 1-3, 2020 for the 56th edition of the International Conference on Medicinal Chemistry (RICT 2020).

The congress will be devoted to “Interfacing Chemical Biology and Drug Discovery".

As for previous editions of RICT, the scientific committee will ensure the high quality and diversity of the scientific programme together with the accessibility of the meeting to PhD/post-doc and local Master students. For the latter, an advantageous registration fee is proposed. Moreover, a special career session will be organised with industrial and academic participants.

In addition, a poster session will provide the opportunity for all participants to present their current results. “Best poster” prizes will be attributed at the end of the meeting.

For more information contact:

Organised by:
  • Société de Chimie Thérapeutique (France)

August 23 - 27, 2020
San Francisco, California

ACS organizes two national meetings & expositions each year, and each one attracts an estimated 11,000 to 13,000 chemists, chemical engineers, academicians, graduate and undergraduate students, and other related professionals. During the meeting, scientists present new multidisciplinary research, hear the latest information in their areas of professional interest, and network with colleagues. Programming is planned by our 33 technical divisions that cover all scientific fields, secretariats that focus on multidisciplinary programming, and ACS committees. Each meeting will feature more than 7,000 presentations organized into technical symposia that highlight important research advances with over 250 exhibitors showcasing new technological developments.

Contact person: Vanessa L. Johnson-Evans
Email:

September 2020
date and venue to be confirmed
Organised by:
  • Organic and Medicinal Chemistry Division (OMCD) of the Hungarian Chemical Society (HCS) (Hungary)

September 2-5, 2020
Heidelberg, Germany

The conference sets the stage for the dissemination and exchange of new developments in diverse, hot fields within chemical biology, being the platform for inspiration, collaboration and networking for researchers in academia and industry. It is the largest, and longest standing conference in the field, giving over 300 participants multiple opportunities to actively participate. The aim is to provide the possibility for every chemical biologist to meet and discuss with peers, from tool development to biological applications, from computational drug design to synthetic chemistry. Most importantly, participants come to see where the field stands in its full breadth.

Session Topics:

  • Drug and target discovery
  • Glyco- and phospho- chemical biology
  • Chemical optogenetics
  • Origin of life
  • Sensing and probes
  • Protein modifications
  • Cellular reprogramming and synthetic biology
Dedaline for abstract submission is June 15, 2020.

Deadline for registration is July 16, 2020.

For more information please contact: 


EFMC Symposium

September 6-10, 2020
Basel, Switzerland

The XXVI EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2020) is organised by the Division of Medicinal Chemistry and Chemical Biology of the Swiss Chemical Society (SCS), on behalf of the European Federation for Medicinal Chemistry (EFMC).

The symposium will take place in Basel from September 6-10, 2020.

The 2020 edition will continue the tradition established for these biennial symposia of covering advances in drug discovery in major therapeutic areas, including the treatment of bacterial and viral infections, diseases related to the CNS, heart disease, fibrotic diseases and cancer.

EFMC-ISMC 2020 will also present most recent advances in highly topical areas such as, for example, the application of artificial intelligence in drug discovery and in synthesis, carbohydrate recognition and drug design, the targeting of RNA, small molecule-induced stem cell differentiation, and the impact of cryo-EM on drug discovery and design. In a series of Chemical Biology sessions, the interface between chemical biology and drug discovery will be highlighted by discussing the use of chemical probes for target discovery, aspects of molecular imaging, and photochemical approaches. In response to frequent requests by attendees of previous conferences, several sessions will be dedicated to advances in synthetic methodology for drug discovery. Finally, particular emphasis will again be put on first time disclosures and recent highlights in medicinal chemistry.

The EFMC is the main organisation for the European Medicinal Chemistry community, with 26 member societies and about 7.500 members. Its biennial EFMC-ISMC is a key symposium in the field of medicinal chemistry and drug discovery and it traditionally attracts around 1.000 participants both from industry and academia. The last 5 EFMC-ISMC meetings took place in Belgium (Brussels, 2010), Germany (Berlin, 2012), Portugal (Lisbon, 2014), in the United Kingdom (Manchester, 2016), and Slovenia (Ljubljana, 2018).

We look forward to welcoming you in Basel in September!

Organised by:
  • Division for Medicinal Chemistry & Chemical Biology (DMCCB) (Switzerland)
  • European Federation of Medecinal Chemistry (EFMC)


EFMC Symposium

September 10-11, 2020
Basel, Switzerland

The EFMC Young Medicinal Chemist Symposium is an initiative of the European Federation for Medicinal Chemistry (EFMC). After a successful first edition organised in Lisbon in September 2014, four further meetings have been organised in Antwerp (2015), Manchester (2016), Vienna (2017), Ljubljana (2018) and Athens (2019). The 7th edition will be organised in connection with the EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2020), and will take place in Basel on September 10-11, 2020.

This short symposium has the aim of:

  • creating a network of young European investigators in Medicinal Chemistry
  • stimulating young European investigators in Medicinal Chemistry to share their scientific work with peers and inspiring leaders in the field
  • creating competition and excellence in Medicinal Chemistry within Europe by selecting the European Champion in Medicinal Chemistry

Stay tuned as more information will be added soon!

Organised by:
  • Division for Medicinal Chemistry & Chemical Biology (DMCCB) (Switzerland)
  • European Federation of Medecinal Chemistry (EFMC)

September 14-15, 2020
Leiden, The Netherlands

At FIGON (the integrative platform for innovative drug research in the Netherlands) they highly value good connections between industry, academia and government. Strong interactions between these stakeholders will increase the societal impact of Dutch drug research. DMD is the conference where all parties involved in drug research in the Netherlands present their findings, share new scientific content and strengthen their networks.

This year’s theme is t.b.d. Many new developments are influencing innovation in our field. Big data and artificial intelligence (AI) open new doors in all stages from drug discovery to clinical practice. Other developments, such as options to intervene at the RNA level, quicker ways to screen promising small molecules, and the pressing need for new antibiotics all speed up innovation. These are exciting times in pharmaceutical sciences. Bringing together all bright minds in this field in the Netherlands – established as well as young researchers – the DMD will create momentum for innovation.

Attending the Dutch Medicines Days preparatory meetings with representatives of all FIGON member organisations is always a pleasure. Brainstorm sessions bring together people from many different backgrounds. The programme development process leads to new and sometimes unexpected collaborations.

Deadline for abstract submission is July 4, 2020.

For more information please contact: i.dijkgraaf@maastrichtuniversity.nl

Organised by:
  • Division Medicinal Chemistry & Chemical Biology, Royal Netherlands Chemical Society (KNCV-MCCB) (The Netherlands)

September 17-20, 2020
Lviv, Ukraine

For more information contact: ptchm@ptchm.pl

Organised by:
  • Polish Society of Medicinal Chemistry (Poland)


EFMC Sponsored Event

September 21-23, 2020
Verona, Italy

The key role of G protein-coupled receptors (GPCRs) in human disease underpins their importance to modern medicine. We are pleased to announce that Evotec, Italy will support the eighth meeting in this series on GPCR drug discovery, which will combine cutting edge medicinal chemistry with innovative structural biology and novel drug design approaches.

Deadline for abstract submission for oral communication is January 13, 2020.

Deadline for abstract submission for poster presentation is July 22, 2020.

Bursary application deadline is August 7, 2020.

For more information please contact: 

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)

October 22-23, 2020
Albacete, Spain

The Spanish Society of Medicinal Chemistry (SEQT) has the pleasure to invite you to join the XIII SEQT Symposium, scheduled to be held on October 22-23, 2020 at Faculty of Pharmacy facilities in Albacete (Spain). This event will be an excellent opportunity to merge together highly experienced senior scientists from Spain and other European countries, imparting invited and plenary lectures, with students (post-graduated and postdoctoral) and junior researchers. As in previous editions, attendees will have the opportunity to access the latest advances and trends in drug discovery from both an academy and industry perspective.

For more inforation contact: 

Organised by:
  • Sociedad Española de Química Terapéutica (Spain)

November 10-13, 2020
Atlanta, United States

To promote research, education, and translational impact at the interface of chemistry and biology, ICBS2020 will bring together students, scientists, educators, publishers, and other interested participants across academia, industry, government, and non-profit organizations around the world. As innovative chemistry, novel technologies, and conceptual advances in chemical biology are transforming the landscape of life sciences and health industry, it is timely for chemical biologists from both academic and industry perspectives to highlight new discoveries and breakthroughs, discuss opportunities and challenges, and identify emerging concepts and synergisms. To maximize active interactions, ICBS2020 will feature thought leaders for keynote and plenary lectures, Rising Stars, focused sessions on specialized topics, students and postdoc-oriented Young Chemical Biologist Forum, and podium flash presentations. 

For more information please contact Dr Tiffany Bell-Horwath at

December 2020
The Netherlands
Organised by:
  • Division Medicinal Chemistry & Chemical Biology, Royal Netherlands Chemical Society (KNCV-MCCB) (The Netherlands)

March 21-25, 2021
San Antonio, Texas

June 16-18, 2021
Denmark

August 22-26, 2021
Atlanta, Georgia


EFMC Symposium

August 29 - September 2, 2021
Zagreb, Croatia

Symposium Chairs: 

  • Prof. Karl Gademann, Universirty of Zurich, Switzerland
  • Dr Ingo Hartung, Merck, Germany 
Organised by:
  • Croatian Chemical Society, Section of Medicinal/Pharmaceutical Chemistry (Croatia)
  • European Federation of Medecinal Chemistry (EFMC)

September 26-29, 2019
Brazil

March 20-24, 2022
San Diego, California

August 21-25, 2022
Chicago, Illinois


EFMC Symposium

September 4-8, 2022
Nice, France
Organised by:
  • Société de Chimie Thérapeutique (France)
  • European Federation of Medecinal Chemistry (EFMC)

March 26-30, 2023
Indianapolis, Indiana

August 13-17, 2023
San Francisco, California

March 17-21, 2024
New Orleans, Louisianna

August 18-24, 2024
Denver, Colorado

March 23-27, 2025
San Diego, California

August 17-21, 2025
Washington, District of Columbia